IL10 and metabolic dysfunction-associated steatotic liver disease: Based on statistical analysis of patient data, the gut microbes related to NAFLD-HCC seemed to activate the expansion of effector IL-10+ Tregs and restrain the expansion of cytotoxic CD8+ T cells partially via the effects of SCFAs [28].